Navigating Polycythemia Vera (PV): Symptom Recognition and Management - Episode 1
Polycythemia Vera: Overview
December 18, 2024
A panelist discusses how polycythemia vera (PV) is a rare myeloproliferative neoplasm (MPN) characterized by excessive red blood cell production, primarily affecting older adults with JAK2 mutations, and while it can be managed with treatment, patients face increased risks of blood clots and potential progression to more serious conditions.
Video content above is prompted by the following:
- What is PV?
- How is PV similar/different compared with other MPNs?
- Who is at risk for PV (age, gender, genetic factors)?
What is the prognosis?
Related Content:
